Senior insider sale
VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$133.0K
266.00 shares
What this filing means
BHATIA SANGEETA N. plans to sell 266.00 shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $133.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/13/2026ACC: 0001959173-26-000976
Director
Since Oct 2018
266.00
Shares to sell
$133.0K
Approx. market value
266.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
5/1/2024
266.00Total acquired266.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/1/2024 | Restricted Stock Vesting Compensation | 266.00 | — |
| Total | 266.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
266.00
Market value
$133.0K
2/13/2026
Total
Units
266.00
Value
$133.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/13/2026 | 266.00 | $133.0K | NASDAQ | Planned |
| Total | 266.00 | $133.0K | ||